Los Angeles, CA, United States of America

Rhonda R Voskuhl

This inventor holds 17 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Neurodegenerative Treatments. Top assignee: University of California. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rhonda R Voskuhl. Retrieved from https://idiyas.com/inventor/rhonda-r-voskuhl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 88.2

 

 

Average Co-Inventor Count = 1.1

ph-index = 6

Forward Citations = 126(Granted Patents)


Location History:

  • West Hollywood, CA (US) (2005 - 2013)
  • Los Angeles, CA (US) (2014 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Estrogen Therapy
Neurodegenerative Diseases
Cognitive Function
Multiple Sclerosis
Estriol Therapy
Pharmaceutical Packaging
Hormonal Treatments
Autoimmune Diseases
17 patents (USPTO):Explore Patents

Title: Rhonda R Voskuhl: Innovator in Neurodegenerative Disease Treatment

Introduction

Rhonda R Voskuhl is a prominent inventor based in Los Angeles, CA, known for her significant contributions to the field of neurodegenerative diseases. With a total of 17 patents to her name, Voskuhl has dedicated her research to developing innovative treatments that address critical health issues.

Latest Patents

Among her latest patents is the invention titled "Estrogen therapy for brain gray matter atrophy and associated disability." This patent provides methods for slowing, halting, and reversing gray matter atrophy and the progression of disability in certain neurodegenerative diseases, including multiple sclerosis, using estrogen, either alone or in combination with another agent. Another notable patent is "Estrogen receptor ligand treatment for neurodegenerative diseases," which relates to the treatment of neurological diseases such as multiple sclerosis and Alzheimer's disease, utilizing an estrogen receptor beta (ERβ) ligand.

Career Highlights

Rhonda Voskuhl is affiliated with the University of California, where she continues her research and innovation in the field of neurodegenerative diseases. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from these debilitating conditions.

Collaborations

One of her notable collaborators is Michael E Jung, with whom she has worked on various research projects aimed at advancing the understanding and treatment of neurodegenerative diseases.

Conclusion

Rhonda R Voskuhl's innovative work in the treatment of neurodegenerative diseases highlights her commitment to improving health outcomes through research and invention. Her contributions continue to pave the way for new therapeutic approaches in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…